AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

DOPAMINE

8 registrations across 4 African markets— 6 active

Markets with DOPAMINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
MEDOPA 200MG/5ML SOLUTION POUR PERFUSION EN IV FLACON DE 5ML🇨🇮Côte d'IvoireLABORATOIRE MEDINFARexpiredJan 2026
DOPAMINE
Solution injectable / 50 MG
🇹🇳TunisiaPIERRE FABRE MEDICAMENTexpiredNov 1993
DOPA PLUS
Injection
🇹🇿TanzaniaVHB MEDI SCIENCES LIMITEDactive
DOPAMINE PIERRE FABRE
SOLUTION POUR PERFUSION
🇲🇦Moroccoactive
DOPAMINE AGUETTANT 40MG/ML
SOLUTION POUR PERFUSION
🇲🇦Moroccoactive
DOPAMINE PIERRE FABRE
SOLUTION A DILUER POUR PERFUSION
🇲🇦Moroccoactive
DOPAMINE AGUETTANT 10MG/ML
SOLUTION POUR PERFUSION
🇲🇦Moroccoactive
Delstrigo Film
Film Coated Tablet
🇹🇿TanzaniaMSD (PTY) LTDactive

DOPAMINE in Africa — Regulatory Overview

DOPAMINE is registered across 4 African markets with 8 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Tanzania, Côte d'Ivoire, Tunisia. AfricaRegulatory refreshes this data daily from official government sources.

Of the 8 registrations, 6 (75%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.